Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Medtronic
Harvard Business School
Johnson and Johnson
Colorcon

Last Updated: June 30, 2022

CLINICAL TRIALS PROFILE FOR SANCUSO


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Sancuso

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00186628 ↗ Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Completed National Cancer Institute (NCI) Phase 2 2005-06-01 To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD)
NCT00186628 ↗ Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Completed The Leukemia and Lymphoma Society Phase 2 2005-06-01 To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD)
NCT00186628 ↗ Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD Completed Stanford University Phase 2 2005-06-01 To determine if rituximab administered after allogeneic transplantation decreases the incidence of chronic graft-vs-host disease (cGvHD)
NCT00450801 ↗ R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma Completed University of Miami Phase 2 2004-04-01 RATIONALE: To evaluate the efficacy of a new high intensity chemotherapy regimen with thalidomide maintenance in patients with newly diagnosed mantle cell lymphoma PURPOSE: This phase II trial is studying how well giving rituximab together with combination chemotherapy followed by thalidomide works in treating patients with previously untreated mantle cell lymphoma.
NCT00868764 ↗ An Investigation on the Effect of Age and BMI on the Pharmacokinetics of Transdermal Granisetron Completed Prostrakan Pharmaceuticals Phase 1 2009-04-01 This study aims to evaluate the effect of age and BMI on the pharmacokinetics and safety of Sancuso┬«.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sancuso

Condition Name

Condition Name for Sancuso
Intervention Trials
Chemotherapy Induced Nausea and Vomiting 3
Healthy 2
Healthy Volunteers 2
Vomiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Sancuso
Intervention Trials
Vomiting 11
Nausea 8
Lymphoma, Mantle-Cell 2
Postoperative Nausea and Vomiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Sancuso

Trials by Country

Trials by Country for Sancuso
Location Trials
United States 17
Korea, Republic of 2
United Kingdom 2
China 1
Hong Kong 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Sancuso
Location Trials
Texas 3
California 3
Pennsylvania 3
Florida 2
Rhode Island 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Sancuso

Clinical Trial Phase

Clinical Trial Phase for Sancuso
Clinical Trial Phase Trials
Phase 4 3
Phase 3 3
Phase 2 4
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Sancuso
Clinical Trial Phase Trials
Completed 10
Not yet recruiting 2
Withdrawn 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Sancuso

Sponsor Name

Sponsor Name for Sancuso
Sponsor Trials
Prostrakan Pharmaceuticals 6
National Cancer Institute (NCI) 3
Kyowa Kirin Pharmaceutical Development Ltd 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Sancuso
Sponsor Trials
Industry 14
Other 12
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Boehringer Ingelheim
McKesson
Dow
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.